Search Results - "Boen, Hanne M"

Generation of four distinct isogenic cell lines with truncating variants in I-band or A-band titin by Boen, Hanne M., Vandendriessche, Bert, Schippers, Jolien, Rabaut, Laura, Nijak-Paeske, Aleksandra, Ponsaerts, Peter, Van Craenenbroeck, Emeline M., Loeys, Bart, Alaerts, Maaike

“…Truncating variants in TTN (TTNtv) are present in 15–25 % of patients with idiopathic dilated cardiomyopathy. Interestingly, the pathogenicity of TTNtv seems…”
Get full text

Phenotypic spectrum of the first Belgian MYBPC3 founder: a large multi-exon deletion with a varying phenotype by Boen, Hanne M, Alaerts, Maaike, Van Laer, Lut, Saenen, Johan B, Goovaerts, Inge, Bastianen, Jarl, Koopman, Pieter, Vanduynhoven, Philippe, De Vuyst, Elke, Rosseel, Michael, Heidbuchel, Hein, Van Craenenbroeck, Emeline M, Loeys, Bart

“…Variants in the gene are a frequent cause of hypertrophic cardiomyopathy (HCM) but display a large phenotypic heterogeneity. Founder mutations are often…”
Get full text

Variants in structural cardiac genes in patients with cancer therapy-related cardiac dysfunction after anthracycline chemotherapy: a case control study by Boen, Hanne M, Alaerts, Maaike, Goovaerts, Inge, Saenen, Johan B, Franssen, Constantijn, Vorlat, Anne, Vermeulen, Tom, Heidbuchel, Hein, Van Laer, Lut, Loeys, Bart, Van Craenenbroeck, Emeline M

“…Variants in cardiomyopathy genes have been identified in patients with cancer therapy-related cardiac dysfunction (CTRCD), suggesting a genetic predisposition…”
Get full text

Cardiovascular risk factors in cancer survivors: the whole is greater than the sum of parts by Boen, Hanne M, Franssen, Constantijn

Get full text

Diagnostic yield of genetic testing in heart transplant recipients with prior cardiomyopathy by Boen, Hanne M., Loeys, Bart L., Alaerts, Maaike, Saenen, Johan B., Goovaerts, Inge, Van Laer, Lut, Vorlat, Anne, Vermeulen, Tom, Franssen, Constantijn, Pauwels, Patrick, Rodrigus, Inez, Heidbuchel, Hein, Van Craenenbroeck, Emeline M

“…The importance of genetic testing for cardiomyopathies has increased in the last decade. However, in heart transplant patients with former cardiomyopathy,…”
Get full text

Circulating MicroRNA as Biomarkers of Anthracycline-Induced Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review by Boen, Hanne M, Cherubin, Martina, Franssen, Constantijn, Gevaert, Andreas B, Witvrouwen, Isabel, Bosman, Matthias, Guns, Pieter-Jan, Heidbuchel, Hein, Loeys, Bart, Alaerts, Maaike, Van Craenenbroeck, Emeline M

“…Close monitoring for cardiotoxicity during anthracycline chemotherapy is crucial for early diagnosis and therapy guidance. Currently, monitoring relies on…”
Get full text

A mutation update for the FLNC gene in myopathies and cardiomyopathies by Verdonschot, Job A. J., Vanhoutte, Els K., Claes, Godelieve R. F., Helderman‐van den Enden, Apollonia T. J. M., Hoeijmakers, Janneke G. J., Hellebrekers, Debby M. E. I., Haan, Amber, Christiaans, Imke, Lekanne Deprez, Ronald H., Boen, Hanne M., Craenenbroeck, Emeline M., Loeys, Bart L., Hoedemaekers, Yvonne M., Marcelis, Carlo, Kempers, Marlies, Brusse, Esther, Waning, Jaap I., Baas, Annette F., Dooijes, Dennis, Asselbergs, Folkert W., Barge‐Schaapveld, Daniela Q. C. M., Koopman, Pieter, Wijngaard, Arthur, Heymans, Stephane R. B., Krapels, Ingrid P. C., Brunner, Han G.

“…Filamin C (FLNC) variants are associated with cardiac and muscular phenotypes. Originally, FLNC variants were described in myofibrillar myopathy (MFM)…”
Get full text

Circulating MicroRNA as Biomarkers of Anthracycline-Induced Cardiotoxicity by Boen, Hanne M., Cherubin, Martina, Franssen, Constantijn, Gevaert, Andreas B., Witvrouwen, Isabel, Bosman, Matthias, Guns, Pieter-Jan, Heidbuchel, Hein, Loeys, Bart, Alaerts, Maaike, Van Craenenbroeck, Emeline M.

“…Close monitoring for cardiotoxicity during anthracycline chemotherapy is crucial for early diagnosis and therapy guidance. Currently, monitoring relies on…”
Get full text

Circulating MicroRNA as Biomarkers of Anthracycline-Induced Cardiotoxicity: State-of-the-Art Review by Boen, Hanne M., Cherubin, Martina, Franssen, Constantijn, Gevaert, Andreas B., Witvrouwen, Isabel, Bosman, Matthias, Guns, Pieter-Jan, Heidbuchel, Hein, Loeys, Bart, Alaerts, Maaike, Van Craenenbroeck, Emeline M.

“…Close monitoring for cardiotoxicity during anthracycline chemotherapy is crucial for early diagnosis and therapy guidance. Currently, monitoring relies on…”
Get full text